Regulatory · source year

2001 regulatory records

2 selected, source-linked regulatory records dated 2001. This is selective source coverage, not a complete timeline.

Dated records

2 selected records.

Peptide profiles

3 connected profiles.

Cited sources

2 distinct public records.

Cited chronology

Dated source records

Open in the filterable feed →

November 2001

1 record

November 29, 2001

Leuprolide

Drugs@FDA application ANDA075721

The official Drugs@FDA dataset lists original submission 1 for ANDA 075721 with status AP dated 2001-11-29, and names leuprolide acetate among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

→

June 2001

1 record

June 8, 2001

Pramlintide + 1 more

Federal Register notice 01-14410

The Federal Register published notice 01-14410, attributed to FDA and its parent HHS department, on 2001-06-08. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committe; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Pramlintide and Teriparatide.

Source: Federal Register via GovInfo ↗

→